ARC-520

7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Hot on the heels of a clinical hold, Arrowhead torches its clinical pipeline, slashes staff
Endpoints
Wed, 11/30/16 - 09:56 am
Arrowhead Research
R&D
drug development
layoffs
ARC-520
ARC-521
ARC-AAT
Arrowhead spanked with clinical hold in hep B
BioPharma Dive
Thu, 11/10/16 - 04:10 pm
Arrowhead
ARC-520
hepatitis B
Arrowhead Hits Target In Hepatitis B Drug Trial
Investors.com
Thu, 09/24/15 - 11:52 am
Arrowhead Research
hepatitis B
clinical trials
ARC-520
Arrowhead CEO: We feel 'great' about our hepatitis B drug
CNBC
Mon, 11/10/14 - 07:28 pm
Arrowhead Research
hepatitis B
ARC-520
Arrowhead Sinks on Disappointing Hepatitis B Drug Data
TheStreet.com
Wed, 10/8/14 - 10:53 am
Arrowhead Research
hepatitis B
ARC-520
Arrowhead Discloses First Human Hepatitis B Therapy Results
TheStreet.com
Wed, 08/13/14 - 08:28 am
hepatitis B
Arrowhead Research
ARC-520
Arrowhead Surges As Analysts Laud Hepatitis B Drug
Investors.com
Wed, 03/5/14 - 11:49 am
hepatitis B
Arrowhead Research
ARC-520
3 Biotechs Generating a Lot Of Buzz
Wall St Cheat Sheet
Mon, 01/13/14 - 02:47 pm
Celgene
Arrowhead Research
Clovis Oncology
ARC-520
CO-1686
Lucitanib
rucaparib